Rhode Island Hospital study: Bariatric patients with obstructive sleep apnea fail to sho... ( PROVIDENCE R.I. A Rhode Island Hosp...)

Rhode Island Hospital study: Bariatric patients with obstructive sleep apnea fail to show symptoms

Date:8/9/2012

PROVIDENCE, R.I. A Rhode Island Hospital researcher has found that the majority of bariatric surgery patients being treated for obesity have clinically significant obstructive sleep apnea (OSA), but report fewer symptoms than other sleep disorders patients. The study by Katherine M. Sharkey, M.D., Ph.D., of the department of medicine, division of pulmonary, critical care and sleep medicine at Rhode Island Hospital, and University Medicine, is published online in advance of print in the journal Sleep and Breathing.

"Patients with obstructive sleep apnea frequently complain of sleepiness during the daytime, loss of motivation and interest in activities, as well as poor concentration and memory recall," Sharkey said. "However, we found that while the vast majority of patients considering bariatric surgery for treatment of obesity have clinically significant OSA, they report fewer symptoms, and may be attributing daytime napping and decreased functioning to something other than a sleep disorder."

Obstructive sleep apnea is a condition in which the airway becomes narrowed or floppy during sleep, decreasing the flow of air and therefore interrupting breathing during sleep. OSA can be caused by many factors, including obesity. In fact, obese patients have a high prevalence of this sleep disorder, and ultimately are at a higher risk for numerous negative health outcomes including congestive heart failure, coronary artery disease, hypertension and stroke, as well as post-operative respiratory complications and increased perioperative morbidity and mortality following bariatric surgery.

The study identified 269 patients (239 women) who had sleep evaluations prior to bariatric surgery. The patients underwent overnight polysomnography and completed both the Epworth Sleepiness Scale (a questionnaire that asks about a person's tendency to fall asleep) and the Functional Outcomes of Sleep Questionnaire (a questionnaire that asks about how
'/>"/>

Contact: Ellen Slingsby
eslingsby@lifespan.org
401-444-6421
Lifespan
Source:Eurekalert

1

GOOD

Page: 1 2
Related medicine news :

1. Easter Island drug raises cognition throughout life span
2. Hospital of the University of Pennsylvania selected to lead US nurse-training initiative
3. Killer infections targeted by hospital study
4. Implementing a therapeutic hypothermia program for post-cardiac arrest in acute care hospitals
5. Medical complications in hospitalized children: The Canadian Paediatric Adverse Events Study
6. Burnt-Out Nurses Linked to More Hospital Infections
7. In Massachusetts, individual mandate led to decreased hospital productivity
8. Nurse staffing, burnout linked to hospital infections
9. MRSA cases in academic hospitals double in 5 years: study
10. University of Texas Medical Branch to study hospital readmission
11. Lungs respond to hospital ventilator as if it were an infection

Post Your Comments:

(Date:5/20/2013)... (PRWEB) May 20, 2013 Medicare Part ... overwhelmingly satisfied, citing lower costs, convenient access to pharmacies ... Hart Research Associates released today by the Pharmaceutical Care ... seniors (9.5 million) are currently enrolled in plans with ... choices, and overall value of plans with preferred pharmacy ...

(Date:5/20/2013)... 2013 Today, Allayo announced the debut ... A mobile application called Allie helps health care consumers ... takes to arrange for quality health care. Ideal for ... of mobile technology and access to personalized service from ... their health care needs are being met. Allie is ...

(Date:5/20/2013)... Cliff Lake Dental Care is pleased to announce ... when visiting the dentist office . The change was made ... , Here are the new office hours: Mondays- 8 a.m. to ... a.m. to 1 p.m. and 2-5 p.m., Thursdays 7 a.m. to ... be open to take appointments only. Cliff Lake Dental wants to ...

(Date:5/20/2013)... improved health care and significant reductions in drug costs ... between physicians and drug company representatives who promote the ... This system, which has been in place for decades, ... to date on new medications, and always provided generous ... the newest drugs, as well as other supplies and ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 A ... Business Intelligence solutions, i2i Systems announced ... Award-winning Southcentral Foundation (SCF) selected i2iTracks as their ... help them meet their Meaningful Use (MU), Government ... System (UDS) requirements – a welcomed solution to ...

Breaking Medicine News(10 mins):Health News:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2 Health News:Allayo Debuts Virtual Health Assistant At HealthBeat 2013 2 Health News:Cliff Lake Dental Care Announces Office Hours Change 2 Health News:Breakup of physician, drug company relationship could improve health care, cut cost 2 Health News:Breakup of physician, drug company relationship could improve health care, cut cost 3 Health News:Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements 2 Health News:Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements 3

[0] Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices [0] Allayo Debuts Virtual Health Assistant At HealthBeat 2013 [0] Cliff Lake Dental Care Announces Office Hours Change [0] Breakup of physician, drug company relationship could improve health care, cut cost [0] Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements

... most common breast cancer uses the most efficient, powerful ... that system kills it, researchers report. This method ... patients, particularly those resistant to standard therapies such as ... Human estrogen receptor-positive breast cancer cells thriving in a ...

... The second generation drug-eluting stent, everolimus-eluting stent ... in randomised controlled trials over the first ... earlier studies comparing EES with another first ... only demonstrated the non-inferiority of EES; the ...

... order to meet future demands for new pharmaceuticals, ... is dependent on the ongoing development of effective ... Because they are so versatile, organometallic molecules are ... reagents containing zinc atoms have certain advantages over ...

... , MONDAY, Aug. 29 (HealthDay News) -- Boxing ... encourage their kids to find sports that don,t focus ... Those are conclusions from the new policy statement from ... Society that recommends that pediatricians vigorously oppose children participating ...

... Meeting & OTO EXPO of the American Academy of Otolaryngology ... of ear, nose, and throat doctors in the world, will ... more than 386 scientific research sessions, 468 posters, and several ... a unique opportunity for journalists from around the world to ...

... 28 (HealthDay News) -- Although it may sound sweet ... behavior, similar to arguing or slinging insults, Canadian scientists ... Queens University in Kingston, Ontario, also revealed that differences ... live, play a role in how aggressive their shouting ...

Research aims to starve breast cancer cells Clinical outcomes in PCI patients given sirolimus-eluting and everolimus-eluting stents New salts for chemical soups Pediatric Groups Want to KO Boxing for Kids 2011 AAO-HNSF poster presentations Sweet Sparrow Songs May Actually Be Shouting Matches

(Date:5/19/2013)... May 20, 2013 Whole-cell pertussis vaccines were more ... during a large recent outbreak, according to a new ... pertussis vaccines, also called DTwP, were available from the ... that ultimately led to the development of acellular pertussis ... 1990s, the United States had ...

(Date:5/18/2013)... YORK , May 18, 2013 ... law firm, is investigating potential securities fraud at ... AVEO). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... Company and its executives violated federal securities laws ... the Company,s Phase III drug trials for Tivopath ...

(Date:5/17/2013)... , May 17, 2013 Sorrento Therapeutics, ... its Fast-Track Advanced Technology Small Business Technology Transfer ... of Allergy and Infectious Diseases (NIAID), a division ... the development of novel human antibody therapeutics to ... or Staph) infections, including methicillin-resistant S. ...

Breaking Medicine Technology:Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4 Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2 Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2 Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3 Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4

[0] Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak [0] Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm [0] Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases

... today reported one year,survival results from a Phase I/II ... in combination with dacarbazine in,patients with unresectable stage III ... cohort of patients in both the Phase I and,Phase ... the entire patient,set and a 22 month overall mean ...

... (NYSE:,AZN) today announced that the company has submitted ... U.S. Food and Drug,Administration (FDA) for once-daily SEROQUEL ... the treatment of manic,episodes associated with bipolar disorder ... disorder., The bipolar mania submission is based ...

Cached Medicine Technology:AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 2 AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 3 AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 4 AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 2 AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 3 AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 4 AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 5 AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 6 AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 7

AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression

... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...

... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...

... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...

... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...

Medicine Products:

Alligator Micro-Grasper Atraumatic Grasper Reddick Grasper Long Dolphin Nose Grasper